HUP0101822A2 - Pezsegő kompozíciók és eljárás az előállításukra - Google Patents

Pezsegő kompozíciók és eljárás az előállításukra

Info

Publication number
HUP0101822A2
HUP0101822A2 HU0101822A HUP0101822A HUP0101822A2 HU P0101822 A2 HUP0101822 A2 HU P0101822A2 HU 0101822 A HU0101822 A HU 0101822A HU P0101822 A HUP0101822 A HU P0101822A HU P0101822 A2 HUP0101822 A2 HU P0101822A2
Authority
HU
Hungary
Prior art keywords
sugar
effervescent
components
preparation
production
Prior art date
Application number
HU0101822A
Other languages
English (en)
Inventor
Petra Ohage
Reinhard Walter
Original Assignee
Bayer Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag. filed Critical Bayer Ag.
Publication of HUP0101822A2 publication Critical patent/HUP0101822A2/hu
Publication of HUP0101822A3 publication Critical patent/HUP0101822A3/hu
Publication of HU224034B1 publication Critical patent/HU224034B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

A találmány gyógyászati hatóanyagot tartalmazó pezsegő kompozícióra éselőállítására vonatkozik. A pezsegő kompozíció A) (i) CO2-forrást és(ii) savas komponenst tartalmazó pezsgő alapból, B) gyógyászatihatóanyagból és C) segédanyagból áll. Az előállításra jellemző, hogyaz A(i), A(ii) komponensek legalább egyikét és adott esetben egyébkomponenseket olvasztott C) cukorban és/vagy cukor-alkoholban és/vagycukorpótlóban diszpergálnak, és a kapott keveréket adott esetbentablettázzák. Az így előállított pezsegő kompozíciók különösenstabilak. Ó
HU0101822A 1998-05-15 1999-05-03 Pezsegő kompozíciók és eljárás az előállításukra HU224034B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19822036A DE19822036A1 (de) 1998-05-15 1998-05-15 Brausezubereitungen
PCT/EP1999/002969 WO1999059553A1 (de) 1998-05-15 1999-05-03 Brausezubereitungen

Publications (3)

Publication Number Publication Date
HUP0101822A2 true HUP0101822A2 (hu) 2002-03-28
HUP0101822A3 HUP0101822A3 (en) 2002-12-28
HU224034B1 HU224034B1 (hu) 2005-05-30

Family

ID=7868010

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101822A HU224034B1 (hu) 1998-05-15 1999-05-03 Pezsegő kompozíciók és eljárás az előállításukra

Country Status (30)

Country Link
EP (1) EP1077684B1 (hu)
JP (1) JP4452403B2 (hu)
KR (1) KR100629817B1 (hu)
AR (1) AR016473A1 (hu)
AT (1) ATE246494T1 (hu)
AU (1) AU3929799A (hu)
BR (1) BR9910454A (hu)
CA (1) CA2331671C (hu)
CO (1) CO4830457A1 (hu)
CZ (1) CZ300778B6 (hu)
DE (2) DE19822036A1 (hu)
DK (1) DK1077684T3 (hu)
EE (1) EE04701B1 (hu)
ES (1) ES2203134T3 (hu)
GT (1) GT199900062A (hu)
HN (1) HN1999000067A (hu)
HR (1) HRP20000781B1 (hu)
HU (1) HU224034B1 (hu)
ID (1) ID27441A (hu)
IL (1) IL139240A (hu)
NO (1) NO20005722L (hu)
PA (1) PA8472001A1 (hu)
PE (1) PE20000465A1 (hu)
PL (1) PL194347B1 (hu)
PT (1) PT1077684E (hu)
SI (1) SI1077684T1 (hu)
SK (1) SK284621B6 (hu)
TR (1) TR200003357T2 (hu)
UY (1) UY25510A1 (hu)
WO (1) WO1999059553A1 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
EP1150660B1 (de) * 1999-02-11 2004-01-21 Hexal Ag Pharmazeutische, metamizol enthaltende brauseformulierung
FR2823668B1 (fr) * 2001-04-20 2004-02-27 Ethypharm Lab Prod Ethiques Comprimes effervescents orodispersibles
WO2006082499A1 (en) * 2005-02-03 2006-08-10 Nycomed Pharma As Melt granulation of a composition containing a calcium-containing compound
GR1007299B (el) * 2010-03-24 2011-06-06 Uni - Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Αβεε, Πρωτοτυπη αναβραζουσα φαρμακευτικη συνθεση υδροχλωρικης μετφορμινης με τη μορφη δισκιου
WO2013022410A2 (en) 2011-08-08 2013-02-14 Mahmut Bilgic Production method for effervescent formulations comprising dexketoprofen
EP3193843A1 (en) 2014-09-17 2017-07-26 Steerlife India Private Limited Effervescent composition and method of making it
US11559483B2 (en) * 2015-07-10 2023-01-24 Sanjay Gupta Nasal foam via cribriform plate for medication delivery to the brain and/or body and for nasal moisturization and hygiene
WO2017098481A1 (en) * 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
JP2018183067A (ja) * 2017-04-24 2018-11-22 株式会社松原製餡所 発泡性添加物、及び、餡食品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004036A (en) * 1966-05-31 1977-01-18 Alberto Culver Company Effervescent molded triturate tablets
US3653914A (en) * 1970-03-20 1972-04-04 Alberto Culver Co Production of tablets
DE69102900T3 (de) * 1990-02-14 1998-04-09 Otsuka Pharma Co Ltd Brausemischung, deren Herstellung sowie Verwendung.
RU2096955C1 (ru) * 1991-03-01 1997-11-27 Е.И.Дюпон Де Немур Энд Компани Вододиспергируемая гранулированная пестицидная композиция, получаемая методом экструзии, и способ ее получения
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
HU217125B (hu) * 1993-03-10 1999-11-29 Béres Rt. Cukor- és nátriummentes pezsgőtabletta és -granulátum és eljárás azok előállítására
AU677432B2 (en) * 1993-09-09 1997-04-24 Gerhard Gergely Effervescent granulated material and method for its preparation
GB2307857B (en) * 1995-12-04 1999-01-27 Euro Celtique Sa An effervescent formulation

Also Published As

Publication number Publication date
AR016473A1 (es) 2001-07-04
CZ20004171A3 (cs) 2001-03-14
DE59906519D1 (de) 2003-09-11
EP1077684B1 (de) 2003-08-06
ID27441A (id) 2001-04-12
SI1077684T1 (en) 2003-12-31
HN1999000067A (es) 1999-09-29
PA8472001A1 (es) 2000-09-29
BR9910454A (pt) 2001-01-02
JP2002515422A (ja) 2002-05-28
UY25510A1 (es) 1999-12-13
PE20000465A1 (es) 2000-07-07
SK17062000A3 (sk) 2001-04-09
AU3929799A (en) 1999-12-06
KR20010043600A (ko) 2001-05-25
PT1077684E (pt) 2003-12-31
GT199900062A (es) 2000-10-20
EP1077684A1 (de) 2001-02-28
NO20005722D0 (no) 2000-11-13
JP4452403B2 (ja) 2010-04-21
NO20005722L (no) 2001-01-15
CA2331671A1 (en) 1999-11-25
CZ300778B6 (cs) 2009-08-12
HUP0101822A3 (en) 2002-12-28
IL139240A (en) 2005-08-31
DE19822036A1 (de) 1999-11-18
ES2203134T3 (es) 2004-04-01
HU224034B1 (hu) 2005-05-30
SK284621B6 (sk) 2005-07-01
PL344140A1 (en) 2001-10-08
EE04701B1 (et) 2006-10-16
CA2331671C (en) 2008-01-08
EE200000650A (et) 2002-04-15
CO4830457A1 (es) 1999-08-30
PL194347B1 (pl) 2007-05-31
TR200003357T2 (tr) 2001-05-21
DK1077684T3 (da) 2003-11-17
HRP20000781A2 (en) 2001-06-30
HRP20000781B1 (en) 2010-06-30
WO1999059553A1 (de) 1999-11-25
KR100629817B1 (ko) 2006-09-29
IL139240A0 (en) 2001-11-25
ATE246494T1 (de) 2003-08-15

Similar Documents

Publication Publication Date Title
WO2004033418A3 (en) Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists
NO20034230D0 (no) 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
IL155806A0 (en) Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
WO2002098413A3 (en) Pharmaceutical compositions comprising orlistat and fatty acids and/or salts thereof
ATE429210T1 (de) Orale flüssige zusammensetzungen
TW200514772A (en) Novel tetrahydropyridine derivatives
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
WO2004026836A3 (en) 1-pyridin-4-yl-urea derivatives
HUP0101822A2 (hu) Pezsegő kompozíciók és eljárás az előállításukra
WO2003101421A8 (de) Wirkstoffhaltige filmförmige zubereitungen mit verbesserter chemischer stabilität, und verfahren zu deren herstellung
DE69836678D1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
ATE215817T1 (de) Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
MXPA04001252A (es) Nuevos heterociclos benzo-fusionados como antagonistas de endotelina.
HUP0001769A2 (hu) Lakrofil készítmény alkalmazása gyógyászati hatóanyag-tartalmú szemcseppekben
WO2002024665A8 (en) Arylalkane-sulfonamides having endothelin-antagonist activity
MY140724A (en) Novel arylethene-sulfonamides
WO2003028624A3 (en) Levothyroxine compositions and methods
WO2003013441A3 (en) Levothyroxine compositions and methods
MXPA02006250A (es) Derivados de butino diol.
MXPA05012655A (es) Isomeros puros d-(17a)-13 -etil-17-hidroxi -18, 19-dinorpregn- 4-eno-20-ino -3-ona-3e -y ??3z- oxima, asi como el proceso para la sintesis de la mezcla de isomeros y los isomeros puros.
CA2099585A1 (en) Pharmaceutical compositions
UA39339A (uk) Спосіб отримання гіполіпідемічного засобу в таблетках
MXPA03007332A (es) Composiciones de levotiroxina y metodos para elaborar la misma.
RU94039363A (ru) Способ получения комбинированного лекарственного препарата в твердых желатиновых капсулах

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20050322

GB9A Succession in title

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE

Free format text: FORMER OWNER(S): BAYER AG., DE; BAYER HEALTHCARE AG., DE

GB9A Succession in title

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

Free format text: FORMER OWNER(S): BAYER AG., DE; BAYER HEALTHCARE AG., DE; BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE